BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38054742)

  • 1. A workflow for the enrichment, the identification, and the isolation of non-apoptotic single circulating tumor cells for RNA sequencing analysis.
    Abramova A; Rivandi M; Yang L; Stamm N; Cieslik JP; Honisch E; Niederacher D; Fehm T; Neubauer H; Franken A
    Cytometry A; 2024 Apr; 105(4):242-251. PubMed ID: 38054742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch
    Neumann MH; Schneck H; Decker Y; Schömer S; Franken A; Endris V; Pfarr N; Weichert W; Niederacher D; Fehm T; Neubauer H
    Biotechnol Prog; 2017 Jan; 33(1):125-132. PubMed ID: 27126369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products.
    Franken A; Driemel C; Behrens B; Meier-Stiegen F; Endris V; Stenzinger A; Niederacher D; Fischer JC; Stoecklein NH; Ruckhaeberle E; Fehm T; Neubauer H
    Clin Chem; 2019 Apr; 65(4):549-558. PubMed ID: 30737205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM
    Lampignano R; Yang L; Neumann MHD; Franken A; Fehm T; Niederacher D; Neubauer H
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing microwell slides for detection and isolation of single circulating tumor cells from complex cell suspensions.
    Yang L; Rivandi M; Franken A; Hieltjes M; van der Zaag PJ; Nelep C; Eberhardt J; Peter S; Niederacher D; Fehm T; Neubauer H
    Cytometry A; 2022 Dec; 101(12):1057-1067. PubMed ID: 35698878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance.
    Reinhardt F; Franken A; Meier-Stiegen F; Driemel C; Stoecklein NH; Fischer JC; Niederacher D; Ruckhaeberle E; Fehm T; Neubauer H
    Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
    Pestrin M; Salvianti F; Galardi F; De Luca F; Turner N; Malorni L; Pazzagli M; Di Leo A; Pinzani P
    Mol Oncol; 2015 Apr; 9(4):749-57. PubMed ID: 25539732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining.
    Campton DE; Ramirez AB; Nordberg JJ; Drovetto N; Clein AC; Varshavskaya P; Friemel BH; Quarre S; Breman A; Dorschner M; Blau S; Blau CA; Sabath DE; Stilwell JL; Kaldjian EP
    BMC Cancer; 2015 May; 15():360. PubMed ID: 25944336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Modified Method to Isolate Circulating Tumor Cells and Identify by a Panel of Gene Mutations in Lung Cancer.
    Wang H; Wu J; Zhang Q; Hao J; Wang Y; Li Z; Niu H; Zhang H; Zhang S
    Technol Cancer Res Treat; 2021; 20():1533033821995275. PubMed ID: 34032165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.
    Fischer JC; Niederacher D; Topp SA; Honisch E; Schumacher S; Schmitz N; Zacarias Föhrding L; Vay C; Hoffmann I; Kasprowicz NS; Hepp PG; Mohrmann S; Nitz U; Stresemann A; Krahn T; Henze T; Griebsch E; Raba K; Rox JM; Wenzel F; Sproll C; Janni W; Fehm T; Klein CA; Knoefel WT; Stoecklein NH
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16580-5. PubMed ID: 24065821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated enrichment system to facilitate isolation and molecular characterization of single cancer cells from whole blood.
    Yu L; Sa S; Wang L; Dulmage K; Bhagwat N; Yee SS; Sen M; Pletcher CH; Moore JS; Saksena S; Dixon EP; Carpenter EL
    Cytometry A; 2018 Dec; 93(12):1226-1233. PubMed ID: 30549400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
    Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
    PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
    Philippron A; Depypere L; Oeyen S; De Laere B; Vandeputte C; Nafteux P; De Preter K; Pattyn P
    PLoS One; 2021; 16(5):e0251052. PubMed ID: 33961658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Tumor Cell Enrichment and Single-Cell Isolation Combining the CellSearch
    Köstler C; Polzer B; Alberter B
    Methods Mol Biol; 2024; 2752():11-42. PubMed ID: 38194025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients.
    Payne RE; Wang F; Su N; Krell J; Zebrowski A; Yagüe E; Ma XJ; Luo Y; Coombes RC
    Br J Cancer; 2012 May; 106(11):1790-7. PubMed ID: 22538972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
    Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
    Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved platform for breast cancer circulating tumor cell enrichment and characterization with next-generation sequencing technology.
    Mihalcioiu C; Li J; Badescu D; Camirand A; Kremer N; Bertos N; Omeroglu A; Sebag M; Di Battista J; Park M; Ragoussis J; Kremer R
    Am J Cancer Res; 2023; 13(1):25-44. PubMed ID: 36777514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
    Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.